Feng Guo
Chief Executive Officer chez GENOR BIOPHARMA HOLDINGS LIMITED
Fortune : 933 429 $ au 31/03/2024
Profil
Feng Guo is currently the Chairman & Chief Executive Officer at Genor Biopharma Co., Ltd.
and Genor Biopharma Holdings Ltd.
He previously served as the Chief Executive Officer at Tayu Huaxia Biotech Medical Group Co Ltd from 2017 to 2018, the Associate Director-Pfizer Global R&D at Pfizer Inc. from 2002 to 2013, and the Executive Director & Vice President at Sihuan Pharmaceutical Holdings Group Ltd.
from 2017 to 2018.
Dr. Guo holds a doctorate degree from the University of Toronto, which was conferred in 2001.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/04/2024 | 5 891 375 ( 1,16% ) | 933 429 $ | 31/03/2024 |
Postes actifs de Feng Guo
| Sociétés | Poste | Début |
|---|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Chief Executive Officer | 16/04/2020 |
Genor Biopharma Co., Ltd.
 Genor Biopharma Co., Ltd. BiotechnologyHealth Technology Genor Biopharma Co., Ltd. engages in the manufacture and development of antibodies and related biological products. Its business scope includes research and development of monoclonal antibodies and biological products; research and development of instruments, equipment and reagents related to monoclonal antibodies and biological products; and wholesale, import and export of instruments, mechanical equipment, pharmaceutical equipment, and pharmaceutical intermediates. The company was founded on December 4, 2007 and is headquartered in Shanghai, China. | Chief Executive Officer | 01/04/2020 |
Anciens postes connus de Feng Guo
| Sociétés | Poste | Fin |
|---|---|---|
| Tayu Huaxia Biotech Medical Group Co Ltd | Chief Executive Officer | 01/12/2018 |
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. | Director/Board Member | 20/04/2018 |
| PFIZER, INC. | Corporate Officer/Principal | 01/04/2013 |
Formation de Feng Guo
| University of Toronto | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. | Health Technology |
| GENOR BIOPHARMA HOLDINGS LIMITED | Health Technology |
| Entreprise privées | 2 |
|---|---|
Genor Biopharma Co., Ltd.
Genor Biopharma Co., Ltd. BiotechnologyHealth Technology Genor Biopharma Co., Ltd. engages in the manufacture and development of antibodies and related biological products. Its business scope includes research and development of monoclonal antibodies and biological products; research and development of instruments, equipment and reagents related to monoclonal antibodies and biological products; and wholesale, import and export of instruments, mechanical equipment, pharmaceutical equipment, and pharmaceutical intermediates. The company was founded on December 4, 2007 and is headquartered in Shanghai, China. | Health Technology |
| Tayu Huaxia Biotech Medical Group Co Ltd |
